BO

Bradley O'Connor

Cogstate Limited | Chief Executive Officer, Managing Director
Mr O'Connor has responsibility for overall strategic direction and day-to-day operations as well as development of expansion opportunities outside of the core clinical trials business. Prior to that, Mr O'Connor held senior positions at Spherion Group, Australian Wine Exchange and PricewaterhouseCoopers.

Company and Roles

Company
Title
Tenure
Since
CGS
Cogstate Limited
  • Chief Executive Officer
  • Managing Director
19yrsNov 2005

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CGS
Cogstate Limited
10/09/244,488,429949,6732,250,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CGS
Cogstate Limited
06/11/24
Issued
920,251$1.000$920,251Issue of securities
CGS
Cogstate Limited
10/09/24
Exercise
1,000,000$0.340$340,000Exercise of options
CGS
Cogstate Limited
10/09/24
Issued
1,000,000$0.340$340,000Exercise of options
CGS
Cogstate Limited
07/03/23
Buy
32,500$1.545$50,205On-market trade
CGS
Cogstate Limited
07/03/23
Buy
32,500$1.544$50,169On-market trade